Volume 22, Number 10—October 2016
Letter
Unmet Needs for a Rapid Diagnosis of Chikungunya Virus Infection
Table
Reported sensitivity and specificity of rapid point-of-care tests for detecting chikungunya virus, 2008–2015*
Reference and test(s) | Time from symptom onset to testing, d | Sensitivity, %‡ | Specificity, %‡ | Test reference standard |
---|---|---|---|---|
(1) | ||||
OnSite Chikungunya IgM Rapid Test | 1 to >21 | 20.5 | 100 | Capture ELISA IgM (in house) with Asian lineage virus; rRT-PCR |
SD BIOLINE Chikungunya IgM test |
1 to >21 |
50.8 |
89.2 |
Capture ELISA IgM (in house) with Asian lineage virus; rRT-PCR |
(2) | ||||
SD BIOLINE Chikungunya IgM test |
<7; 8 to >14§ |
22; 83 |
88; 71 |
ELISA IgM; rRT-PCR |
(3) | ||||
OnSite Chikungunya IgM Rapid Test |
3.75 to >7 |
12.1 |
100 |
IgM IFA; capture ELISA IgM (in house); rRT-PCR |
(4) | ||||
SD BIOLINE Chikungunya IgM test |
3–8 |
1.9–3.9 |
92.5–95.0 |
Capture ELISA IgM; rRT-PCR |
(5) | ||||
OnSite Chikungunya IgM Combo Rapid Test CE | NA | 20 | 93 | Capture ELISA IgM/IgG (in house); plaque reduction neutralization test |
SD BIOLINE Chikungunya IgM test |
NA |
30 |
73 |
Capture ELISA IgM/IgG (in house); plaque reduction neutralization test |
This study | ||||
OnSite Chikungunya IgM Combo Rapid Test CE | 7 to 30 | 37.5 | 100 | IFA IgM/IgG (commercial); rRT-PCR |
*IFA, indirect immunofluorescence assay; NA, not applicable; rRT-PCR, real-time reverse transcription PCR.
†Manufacturers: CTK Biotech, San Diego, CA, USA (OnSite Chikungunya IgM Combo Rapid Test CE and OnSite Chikungunya IgM Rapid Test); Standard Diagnostics, Inc., Seoul, South Korea (SD BIOLINE Chikungunya IgM test).
‡Values are those reported in the original publications.
§Testing was done at 2 different time points after symptom onset.
References
- Kosasih H, Widjaja S, Surya E, Hadiwijaya SH, Butarbutar DP, Jaya UA, Evaluation of two IgM rapid immunochromatographic tests during circulation of Asian lineage chikungunya virus. Southeast Asian J Trop Med Public Health. 2012;43:55–61.PubMedGoogle Scholar
- Rianthavorn P, Wuttirattanakowit N, Prianantathavorn K, Limpaphayom N, Theamboonlers A, Poovorawan Y. Evaluation of a rapid assay for detection of IgM antibodies to chikungunya. Southeast Asian J Trop Med Public Health. 2010;41:92–6.PubMedGoogle Scholar
- Yap G, Pok KY, Lai YL, Hapuarachchi HC, Chow A, Leo YS, Evaluation of chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks. PLoS Negl Trop Dis. 2010;4:e753. DOIPubMedGoogle Scholar
- Blacksell SD, Tanganuchitcharnchai A, Jarman RG, Gibbons RV, Paris DH, Bailey MS, Poor diagnostic accuracy of commercial antibody-based assays for the diagnosis of acute chikungunya infection. Clin Vaccine Immunol. 2011;18:1773–5. DOIPubMedGoogle Scholar
- Prat CM, Flusin O, Panella A, Tenebray B, Lanciotti R, Leparc-Goffart I. Evaluation of commercially available serologic diagnostic tests for chikungunya virus. Emerg Infect Dis. 2014;20:2129–32. DOIPubMedGoogle Scholar
- Okabayashi T, Sasaki T, Masrinoul P, Chantawat N, Yoksan S, Nitatpattana N, Detection of chikungunya virus antigen by a novel rapid immunochromatographic test. J Clin Microbiol. 2015;53:382–8. DOIPubMedGoogle Scholar